Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Report
|
![]() |
Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?Margolis, Marjorie A. ; Brewer, Noel T. ; Shah, Parth D. ; Calo, William A. ; Alton Dailey, Susan ; Gilkey, Melissa B.Human Vaccines & Immunotherapeutics, 2021, Vol.17 (9), p.3077-3080Taylor & FrancisTexto completo disponível |
2 |
Material Type: Report
|
![]() |
Long-term effectiveness of the nine-valent human papillomavirus vaccine in Scandinavian women: interim analysis after 8 years of follow-upKjaer, Susanne K. ; Nygård, Mari ; Sundström, Karin ; Munk, Christian ; Berger, Sophie ; Dzabic, Mensur ; Fridrich, Katrin Elisabeth ; Waldstrøm, Marianne ; Sørbye, Sveinung Wergeland ; Bautista, Oliver ; Group, Thomas ; Luxembourg, AlainHuman Vaccines & Immunotherapeutics, 2021, Vol.17 (4), p.943-949Taylor & FrancisTexto completo disponível |
3 |
Material Type: Report
|
![]() |
Resolution of Harada disease-like uveitis after quadrivalent human papillomavirus vaccination: a case reportKong, Kangjie ; Ding, Xinyi ; Ni, YingqinHuman Vaccines & Immunotherapeutics, 2022, Vol.18 (1), p.1-4Taylor & FrancisTexto completo disponível |
4 |
Material Type: Report
|
![]() |
Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trialsSauvageau, Chantal ; Panicker, Gitika ; Unger, Elizabeth R. ; De Serres, Gaston ; Schiller, John ; Ouakki, Manale ; Gilca, VladimirHuman Vaccines & Immunotherapeutics, 2020, Vol.16 (3), p.590-594Taylor & FrancisTexto completo disponível |
5 |
Material Type: Report
|
![]() |
Myasthenia gravis after the third dose of human papillomavirus 9-valent vaccine: A case reportDing, Yuan ; Fu, Tingbo ; Zhou, Wenbin ; Zhang, Xiaobo ; Wang, Ruying ; Liao, HuiyingHuman Vaccines & Immunotherapeutics, 2023, Vol.19 (2)Taylor & FrancisTexto completo disponível |
6 |
Material Type: Report
|
![]() |
Sexual behavior, clinical outcomes and attendance of cervical cancer screening by HPV vaccinated and unvaccinated sexually active womenSauvageau, Chantal ; Gilca, Vladimir ; Ouakki, Manale ; Kiely, Marilou ; Coutlée, François ; Mathieu-Chartier, Sara ; Defay, Fannie ; Lambert, GillesHuman Vaccines & Immunotherapeutics, 2021, Vol.17 (11), p.4393-4396Taylor & FrancisTexto completo disponível |
7 |
Material Type: Report
|
![]() |
Provider recommendation for HPV vaccination across Hispanic/Latinx subgroups in the United StatesReiter, Paul L. ; Pennell, Michael L. ; Martinez, Glenn A. ; Katz, Mira L.Human Vaccines & Immunotherapeutics, 2021, Vol.17 (4), p.1083-1088Taylor & FrancisTexto completo disponível |
8 |
Material Type: Report
|
![]() |
Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality studyTozawa-Ono, Akiko ; Kamada, Masaharu ; Teramoto, Katsuhiro ; Hareyama, Hitoshi ; Kodama, Shoji ; Kasai, Tokuzo ; Iwanari, Osamu ; Koizumi, Tomoe ; Ozawa, Nobuyoshi ; Suzuki, Mitsuaki ; Kinoshita, KatsuyukiHuman Vaccines & Immunotherapeutics, 2021, Vol.17 (4), p.950-954Taylor & FrancisTexto completo disponível |
9 |
Material Type: Report
|
![]() |
The association between maternal human papillomavirus (HPV) experiences and HPV vaccination of their childrenBiederman, Erika ; Donahue, Kelly ; Sturm, Lynne ; Champion, Victoria ; Zimet, GregoryHuman Vaccines & Immunotherapeutics, 2021, Vol.17 (4), p.1000-1005Taylor & FrancisTexto completo disponível |
10 |
Material Type: Report
|
![]() |
Lacrimal sac ciliated HPV16 positive, adenosquamous carcinoma-A case report of a unique histological variant at this site and a review of the literatureMudhar, Hardeep-Singh ; Tan, Jennifer H Y ; Wagner, Bart E ; Salvi, Sachin MOrbit, 2022, Vol.ahead-of-print (ahead-of-print), p.1-6Taylor & FrancisTexto completo disponível |